The osteogenic differentiation of PDLSCs is mediated through MEK/ERK and p38 MAPK signalling under hypoxia

Archives of Oral Biology

Volumn 58, Issue 10, 2013, Pages 1357-1368

  Wu, Yeke ^a   Yang, Yunqiang ^b   Yang, Pu ^a   Gu, Yifei ^a   Zhao, Zhihe ^a   Tan, Lijun ^a   Zhao, Lixing ^a   Tang, Tian ^a   Li, Yu ^a  

^a SICHUAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Hypoxia; MEK ERK; Osteogenic differentiation; p38 MAPK; Periodontal ligament stem cells

Indexed keywords

ALKALINE PHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN E2; RUNX2 PROTEIN, HUMAN; SP7 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; VASCULOTROPIN A;

ADULT; ANOXIA; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CYTOLOGY; ENZYMOLOGY; FEMALE; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; MEK/ERK; METABOLISM; OSTEOGENIC DIFFERENTIATION; P38 MAPK; PERIODONTAL LIGAMENT; PERIODONTAL LIGAMENT STEM CELLS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL NICHE; WESTERN BLOTTING;

HYPOXIA; MEK/ERK; OSTEOGENIC DIFFERENTIATION; P38 MAPK; PERIODONTAL LIGAMENT STEM CELLS;

ADULT; ALKALINE PHOSPHATASE; ANOXIA; BLOTTING, WESTERN; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DINOPROSTONE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOGENESIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERIODONTAL LIGAMENT; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL NICHE; STEM CELLS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84888057735     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2013.03.011     Document Type: Article

References (48)

1. Brudvik P, Rygh P. The repair of orthodontic root resorption: an ultrastructural study. European Journal of Orthodontics 1995;17(3):189-98.
2. Pradeep AR, Prapulla DV, Sharma A, Sujatha PB. Gingival crevicular fluid and serum vascular endothelial growth factor: their relationship in periodontal health, disease and after treatment. Cytokine 2011;54(2):200-4.
3. Peschkowa LW, Warawa GN, Orlawa OL. New concept on the mechanism of hypoxia in case of periodontitis. Stomatologie der DDR 1990;40(2):67-9.
4. Ku SJ, Chang YI, Chae CH, Kim SG, Park YW, Jung YK, et al. Static tensional forces increase osteogenic gene expression in three-dimensional periodontal ligament cell culture. BMB Reports 2009;42(7):427-32.
5. Jonsdottir SH, Giesen EB, Maltha JC. Biomechanical behaviour of the periodontal ligament of the beagle dog during the first 5 hours of orthodontic force application. European Journal of Orthodontics 2006; 28 (6): 547-52.
6. Rygh P, Bowling K, Hovlandsdal L, Williams S. Activation of the vascular system: a main mediator of periodontal fiber remodeling in orthodontic tooth movement. American Journal of Orthodontics 1986;89(6):453-68.
7. Paris S, Denis H, Delaive E, Dieu M, Dumont V, Ninane N, et al. Up-regulation of 94-kDa glucose-regulated protein by hypoxia-inducible factor-1 in human endothelial cells in response to hypoxia. FEBS Letters 2005; 579(1):105-14.
8. Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn Gelpke MD, et al. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. Journal of the American College of Cardiology 2008;51(13):1258-65.
9. Salim A, Nacamuli RP, Morgan EF, Giaccia AJ, Longaker MT. Transient changes in oxygen tension inhibit osteogenic differentiation and Runx2 expression in osteoblasts. Journal of Biological Chemistry 2004; 279(38):40007-16.
10. Seo BM, Miura M, Gronthos S, Bartold PM, Batouli S, Brahim J, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004;364(9429):149-55.
11. Rygh P, Reitan K. Ultrastructural changes in the periodontal ligament incident to orthodontic tooth movement. Transactions of the European Orthodontic Society 1972:393-405.
12. Wu L, Wei X, Ling J, Liu L, Liu S, Li M, et al. Early osteogenic differential protein profile detected by proteomic analysis in human periodontal ligament cells. Journal of Periodontal Research 2009;44(5):645-56.
13. Raman M, Chen W, Cobb MH. Differential regulation and properties of MAPKs. Oncogene 2007;26(22):3100-12.
14. Chun JS. Expression, activity, and regulation of MAP kinases in cultured chondrocytes. Methods in Molecular Medicine 2004;100:291-306.
15. Schmidt C, Pommerenke H, Durr F, Nebe B, Rychly J. Mechanical stressing of integrin receptors induces enhanced tyrosine phosphorylation of cytoskeletally anchored proteins. Journal of Biological Chemistry 1998;273(9):5081-5.
16. Xiao G, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G, et al. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. Journal of Biological Chemistry 2000;275(6):4453-9.
17. Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Research 2005;15(1):11-8.
18. Huang GT, Gronthos S, Shi S. Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. Journal of Dental Research 2009;88(9):792-806.
19. Kim IS, Song JK, Song YM, Cho TH, Lee TH, Lim SS, et al. Novel effect of biphasic electric current on in vitro osteogenesis and cytokine production in human mesenchymal stromal cells. Tissue Engineering Part A 2009;15(9):2411-22.
20. Mohyeldin A, Garzon-Muvdi T, Quinones-Hinojosa A. Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 2010;7(2):150-61.
21. Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert SR, et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. Journal of Clinical Investigation 2007;117(6):1616-26.
22. Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. Journal of Bone and Mineral Research 2003;18(4):696-704.
23. Huang J, Deng F, Wang L, Xiang XR, Zhou WW, Hu N, et al. Hypoxia induces osteogenesis-related activities and expression of core binding factor alpha1 in mesenchymal stem cells. Tohoku Journal of Experimental Medicine 2011;224(1):7-12.
24. Tamama K, Kawasaki H, Kerpedjieva SS, Guan J, Ganju RK, Sen CK. Differential roles of hypoxia inducible factor subunits in multipotential stromal cells under hypoxic condition. Journal of Cellular Biochemistry 2011;112(3):804-17.
25. Lee SH, Heo JS, Han HJ. Effect of hypoxia on 2-deoxyglucose uptake and cell cycle regulatory protein expression of mouse embryonic stem cells: involvement of Ca2+/PKC, MAPKs and HIF-1alpha. Cellular Physiology and Biochemistry 2007;19(5-6):269-82.
26. Lee SH, Lee YJ, Song CH, Ahn YK, Han HJ. Role of FAK phosphorylation in hypoxia-induced hMSCS migration: involvement of VEGF as well as MAPKS and eNOS pathways. American Journal of Physiology - Cell Physiology 2010;298(4):C847-56.
27. Martin-Rendon E, Hale SJ, Ryan D, Baban D, Forde SP, Roubelakis M, et al. Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia. Stem Cells 2007;25(4):1003-12.
28. Grayson WL, Zhao F, Izadpanah R, Bunnell B, Ma T. Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. Journal of Cellular Physiology 2006;207(2):331-9.
29. Malladi P, Xu Y, Chiou M, Giaccia AJ, Longaker MT. Effect of reduced oxygen tension on chondrogenesis and osteogenesis in adipose-derived mesenchymal cells. American Journal of Physiology - Cell Physiology 2006;290(4):C1139-46.
30. Tamama K, Fan VH, Griffith LG, Blair HC, Wells A. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 2006;24(3):686-95.
31. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007;11(1):69-82.
32. Wan C, Gilbert SR, Wang Y, Cao X, Shen X, Ramaswamy G, et al. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proceedings of the National Academy of Sciences of the United States of America 2008;105(2):686-91.
33. Clarkin CE, Garonna E, Pitsillides AA, Wheeler-Jones CP. Heterotypic contact reveals a COX-2-mediated suppression of osteoblast differentiation by endothelial cells: a negative modulatory role for prostanoids in VEGF-mediated cell: cell communication? Experimental Cell Research 2008;314(17):3152-61.
34. van Wijnen AJ, Stein GS, Gergen JP, Groner Y, Hiebert SW, Ito Y, et al. Nomenclature for Runt-related (RUNX) proteins. Oncogene 2004;23 (24):4209-10.
35. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes and Development 1999;13(8):1025-36.
36. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997;89(5):773-9.
37. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002;108(1):17-29.
38. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/ Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997;89(5):747-54.
39. Bae SC, Lee YH. Phosphorylation, acetylation and ubiquitination: the molecular basis of RUNX regulation. Gene 2006;366(1):58-66.
40. Park JH, Park BH, Kim HK, Park TS, Baek HS. Hypoxia decreases Runx2/Cbfa1 expression in human osteoblast-like cells. Molecular and Cellular Endocrinology 2002;192(1-2): 197-203.
41. Shomento SH, Wan C, Cao X, Faugere MC, Bouxsein ML, Clemens TL, et al. Hypoxia-inducible factors 1alpha and 2alpha exert both distinct and overlapping functions in long bone development. Journal of Cellular Biochemistry 2010;109(1):196-204.
42. Tamiya H, Ikeda T, Jeong JH, Saito T, Yano F, Jung YK, et al. Analysis of the Runx2 promoter in osseous and non-osseous cells and identification of HIF2A as a potent transcription activator. Gene 2008;416(1-2):53-60.
43. Franceschi RT, Ge C, Xiao G, Roca H, Jiang D. Transcriptional regulation of osteoblasts. Annals of the New York Academy of Sciences 2007;1116:196-207.
44. Lou J, Tu Y, Li S, Manske PR. Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2. Biochemical and Biophysical Research Communications 2000;268(3):757-62.
45. New L, Han J. The p38 MAP kinase pathway and its biological function. Trends in Cardiovascular Medicine 1998;8(5):220-8.
46. Alessandrini A, Namura S, Moskowitz MA, Bonventre JV. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proceedings of the National Academy of Sciences of the United States of America 1999;96 (22):12866-9.
47. Cox BD, Natarajan M, Stettner MR, Gladson CL. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. Journal of Cellular Biochemistry 2006;99 (1):35-52.
48. Mottet D, Michel G, Renard P, Ninane N, Raes M, Michiels C. Role of ERK and calcium in the hypoxia-induced activation of HIF-1. Journal of Cellular Physiology 2003; 194 (1):30-44.